Psyence Biomedical Ltd. (PBM) Enterprise Value (2023 - 2026)
Psyence Biomedical (PBM) posted quarterly Enterprise Value of -$7.4 million for Q1 2026, down 20.64% year-over-year from -$9.4 million in Q1 2025, and down 3.44% quarter-over-quarter from -$7.2 million in Q3 2025.
Psyence Biomedical Ltd. (PBM) Enterprise Value (2023 - 2026) Analysis & Trends
Psyence Biomedical's Enterprise Value history runs 4 years deep, the most recent figure standing at -$7.4 million for Q1 2026.
- In Q1 2026, Enterprise Value fell 20.64% year-over-year to -$7.4 million; the TTM figure through Mar 2026 stood at -$7.4 million (down 20.64% YoY), while the FY2026 annual figure was -$7.4 million, down 20.64% from the prior year.
- Enterprise Value for Q1 2026 stood at -$7.4 million, down from -$7.2 million in the prior quarter.
- The five-year high for Enterprise Value was -$605480.0 in Q3 2023, with the low at -$7.4 million in Q1 2026.
- The 4-year median for Enterprise Value is -$1.9 million (2024), against an average of -$3.6 million.
- The sharpest annual moves came in 2024 and 2025: Enterprise Value jumped 44.17% in 2024, then plunged 709.01% in 2025.
- Psyence Biomedical's Enterprise Value stood at -$605480.0 in 2023, then slumped by 219.17% to -$1.9 million in 2024, then slumped by 272.42% to -$7.2 million in 2025, then fell by 3.44% to -$7.4 million in 2026.
- Business Quant data shows PBM's Enterprise Value at -$7.4 million in Q1 2026, -$7.2 million in Q3 2025, and -$6.2 million in Q1 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.44 Mn |
| Sep 30, 2025 | -7.20 Mn |
| Mar 31, 2025 | -6.17 Mn |
| Sep 30, 2024 | -1.93 Mn |
| Mar 31, 2024 | -762,799.00 |
| Sep 30, 2023 | -605,480.00 |
| Mar 31, 2023 | -1.37 Mn |